NSCLC and mCRC Treatment | LUMAKRAS® (sotorasib)
Find information about LUMAKRAS®, a non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC) treatment. See full Prescribing & Safety Info. Indications and Limitations of Use
LUMAKRAS® is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): • that has spread to other parts of the body or cannot be removed by surgery, and • whose tumor has an abnormal KRAS G12C gene, and
How Does LUMAKRAS® work? | LUMAKRAS® (sotorasib)
LUMAKRAS ® is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): that has spread to other parts of the body or cannot be removed by surgery, and whose tumor has an abnormal KRAS G12C gene, and
Amgen Assist 360™ | LUMAKRAS® (sotorasib)
Explore how Amgen Assist 360™ can help support non-small cell lung cancer (NSCLC) patients and their caregivers. See full Prescribing & Safety Info.
ABOUT LUMAKRAS ® (SOTORASIB)
LUMAKRAS ® is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body or cannot be removed by surgery, and whose tumor has an abnormal KRAS G12C gene, and who …
LUMAKRAS™ is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): • that has spread to other parts of the body or cannot be removed by surgery, and • whose tumor has an abnormal KRAS G12C gene, and
What is KRAS G12C? | LUMAKRAS® (sotorasib)
LUMAKRAS ® is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): that has spread to other parts of the body or cannot be removed by surgery, and whose tumor has an abnormal KRAS G12C gene, and
Non-Small Cell Lung Cancer (NSCLC) Treatment | LUMAKRAS® …
Learn about LUMAKRAS®, a treatment for non-small cell lung cancer (NSCLC) that has metastasized and has the KRAS G12C mutation. See full Prescribing & Safety Info. More Close
LUMAKRAS® Clinical Trial Results | LUMAKRAS® (sotorasib)
In a clinical trial, 126 adults were given an oral treatment called LUMAKRAS ®. The trial evaluated how many adults with non-small cell lung cancer (NSCLC) responded to LUMAKRAS ® , meaning their tumors either shrank or disappeared from initial scan.
Contact Us | LUMAKRAS® (sotorasib)
Call Amgen Assist 360 for assistance with your non-small cell lung cancer (NSCLC) diagnosis and LUMAKRAS®. See Full Prescribing & Safety Information.